Abstract
Background
This review aimed to give an updated overview of the occurrence, diagnosis, treatment and outcome of oesophageal and gastric cancer after bariatric and metabolic surgery (BMS).
Methods
Two searches were done (one for original studies and one for systematic reviews) using an adapted form of “sco** review methodology”. MEDLINE, Embase, CINAHL, Pubmed and the Cochrane Library were searched for studies on patients with either oesophageal or gastric cancer after BMS.
Results
A total of 52 unique studies were included which reported on 324 patients, which included 110 (34%) males and 136 (42%) females. In the remaining 78 patients, gender was not specified. A mean of 62.95 ± 32.75 months was the time from BMS to diagnosis of cancer. Most of the patients had a Roux-en-Y gastric bypass (RYGB) as index bariatric surgical procedure, followed by gastric banding (GB) and sleeve gastrectomy (SG) (respectively, 133 (41.0%) RYGB, 97 (30.0%) GB and 58 (18.0%) SG). Seven cases have been reported after OAGB-MGB (3 in gastric remnant, 4 in oesophagus/gastric pouch). Seventy-seven (24%) had distant metastasis (≥ M1/Mx status). The majority of tumours were adenocarcinoma (n = 208, 87.4%). In the majority of the cases, a surgical approach was preferred with either adjuvant chemo or radiotherapy. In the course of the disease, 122 of 324 patients died (37.8%).
Conclusion
To our knowledge, this is the most up-to-date review addressing oesophageal and gastric malignancies after bariatric surgery. Future research should focus to optimise screening for oesophageal and gastric cancer after bariatric surgery.
Graphical abstract
Similar content being viewed by others
References
Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England). 2014;384(9945):766–81.
Arnold M, Ferlay J, van Berge Henegouwen MI, et al. Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut. 2020;69(9):1564–71.
GBD 2017 Oesophageal Cancer Collaborators. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(6):582–97.
Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625–38.
Tsui ST, Yang J, Zhang X, et al. Development of cancer after bariatric surgery. Surg Obes Relat Dis. 2020;16(10):1586–95.
Jaruvongvanich V, Matar R, Ravi K, et al. Esophageal pathophysiologic changes and adenocarcinoma after bariatric surgery: a systematic review and meta-analysis. Clin Transl Gastroenterol. 2020;11(8):e00225.
Silecchia G, Iossa A. GERD and Barrett’s esophagus as indications for revisional surgery after sleeve gastrectomy: experience of a bariatric center of excellence IFSO-EC and narrative review. Expert Rev Endocrinol Metab. 2021;16(5):229–35.
Brown WA, JohariHalim Shah Y, Balalis G, et al. IFSO position statement on the role of esophago-gastro-duodenal endoscopy prior to and after bariatric and metabolic surgery procedures. Obes Surg. 2020;30(8):3135–53.
O’Kane M, Parretti HM, Pinkney J, et al. British Obesity and Metabolic Surgery Society guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery-2020 update. Obes Rev. 2020;21(11):e13087.
Parmar C, Zakeri R, Abouelazayem M, et al. Esophageal and gastric malignancies after bariatric surgery: a retrospective global study. Surg Obes Relat Dis. 2022;18(4):464–72.
Arksey H. Sco** the field: services for carers of people with mental health problems. Health Soc Care Commun. 2003;11(4):335–44.
Levac D, Colquhoun H, O’Brien KK. Sco** studies: advancing the methodology. Implement Sci. 2010;5:69.
Mills C, Reid P, Vaithianathan R. The cost of child health inequalities in Aotearoa New Zealand: a preliminary sco** study. BMC Public Health. 2012;12:384.
Hidalgo Landa A, Szabo I, Le Brun L, et al. Evidence based sco** reviews. Electr J Inf Syst Eval. 2011;14(1):46–52.
The Scottish Intercollegiate Guidelines Network (SIGN): Methodology Checklist 1: systematic reviews and meta-analyses. 2015. http://www.sign.ac.uk/methodology/checklists.html2004. Accessed 01 Sept 2022.
Chemaly R, Diab S, Khazen G, et al. Gastroesophageal cancer after gastric bypass surgeries: a systematic review and meta-analysis. Obes Surg. 2022;32(4):1300–11.
Chen W, Wang Y, Zhu J, et al. Esophagogastric cancer after sleeve gastrectomy: a systematic review of case reports. Cancer Manag Res. 2021;13:3327–34.
Musella M, Berardi G, Bocchetti A, et al. Esophagogastric neoplasms following bariatric surgery: an updated systematic review. Obes Surg. 2019;29(8):2660–9.
Scozzari G, Trapani R, Toppino M, et al. Esophagogastric cancer after bariatric surgery: systematic review of the literature. Surg Obes Relat Dis. 2013;9(1):133–42.
Eldar SM, Ovdat E, Nevo N, et al. Gastric cancer after laparoscopic adjustable gastric banding: a case series. J Obes Weight Loss Ther. 2019;9:380. https://doi.org/10.4172/2165-7904.1000380.
Genco A, Castagneto-Gissey L, Lorenzo M, et al. Esophageal adenocarcinoma after sleeve gastrectomy: actual or potential threat? Italian series and literature review. Surg Obes Relat Dis. 2021;17(5):848–54.
Gehwolf P, Kienzl-Wagner K, Cakar-Beck F, et al. Laparoscopic adjustable gastric banding: an underestimated risk factor for the development of esophageal cancer?-A Nationwide Survey. Obes Surg. 2019;29(2):626–31.
Plat VD, Kasteleijn A, Greve JWM, et al. Esophageal cancer after bariatric surgery: increasing prevalence and treatment strategies. Obes Surg. 2021;31(11):4954–62.
El Khoury L, Benvenga R, Romero R, et al. Esophageal adenocarcinoma in Barrett’s esophagus after sleeve gastrectomy: case report and literature review. Int J Surg Case Rep. 2018;52:132–6.
Bevilacqua LA, Obeid NR, Yang J, et al. Incidence of GERD, esophagitis, Barrett’s esophagus, and esophageal adenocarcinoma after bariatric surgery. Surg Obes Relat Dis. 2020;16(11):1828–36.
Papadia FS, Camerini GB, Carlini F, et al. Management of malabsorptive bariatric surgery after cancer surgery for malignancies of the digestive apparatus. Surg Obes Relat Dis. 2018;14(7):972–7.
Raijman I, Strother SV, Donegan WL. Gastric cancer after gastric bypass for obesity. Case report. J Clin Gastroenterol. 1991;13(2):191–4.
Sweet WA. Linitis plastica presenting as pouch outlet stenosis 13 years after vertical banded gastroplasty. Obes Surg. 1996;6(1):66–70.
Zirak C, Lemaitre J, Lebrun E, et al. Adenocarcinoma of the pouch after silastic ring vertical gastroplasty. Obes Surg. 2002;12(5):693–4.
Papakonstantinou A, Moustafellos P, Terzis I, et al. Gastric cancer occurring after vertical banded gastroplasty. Obes Surg. 2002;12(1):118–20.
Jain PK, Ray B, Royston CM. Carcinoma in the gastric pouch years after vertical banded gastroplasty. Obes Surg. 2003;13(1):136–7.
Snook KL, Ritchie JD. Carcinoma of esophagus after adjustable gastric banding. Obes Surg. 2003;13(5):800–2.
Hackert T, Dietz M, Tjaden C, et al. Band erosion with gastric cancer. Obes Surg. 2004;14(4):559–61.
Allen JW, Leeman MF, Richardson JD. Esophageal carcinoma following bariatric procedures. J Soc Laparoendosc Surg. 2004;8(4):372–5.
de Roover A, Detry O, de Leval L, et al. Report of two cases of gastric cancer after bariatric surgery: lymphoma of the bypassed stomach after Roux-en-Y gastric bypass and gastrointestinal stromal tumor (GIST) after vertical banded gastroplasty. Obes Surg. 2006;16(7):928–31.
Chebib I, Beck PL, Church NG, et al. Gastric pouch adenocarcinoma and tubular adenoma of the pylorus: a field effect of dysplasia following bariatric surgery. Obes Surg. 2007;17(6):843–6.
Melstrom LG, Bentrem DJ, Salvino MJ, et al. Adenocarcinoma of the gastroesophageal junction after bariatric surgery. Am J Surg. 2008;196(1):135–8.
Stroh C, Hohmann U, Urban H, et al. Gastric cancer after laparoscopic adjustable gastric banding. Obes Surg. 2008;18(9):1200–2.
Korswagen LA, Schrama JG, Bruins Slot W, et al. Adenocarcinoma of the lower esophagus after placement of a gastric band. Obes Surg. 2009;19(3):389–92.
Belhaj A, Memmo L, Mehdi A, et al. Gastric adenocarcinoma following “silastic vertical ring gastroplasty”: case report. Rev Med Brux. 2010;31(5):459–62.
Stauffer JA, Mathew J, Odell JA. Esophageal adenocarcinoma after laparoscopic gastric band placement for obesity. Dis Esophagus. 2011;24(1):E8-10.
Scheepers AF, Schoon EJ, Nienhuijs SW. Esophageal carcinoma after sleeve gastrectomy. Surg Obes Relat Dis. 2011;7(4):e11–2.
Trincado MT, del Olmo JC, GarcíaCastaño J, et al. Gastric pouch carcinoma after gastric bypass for morbid obesity. Obes Surg. 2005;15(8):1215–7.
Babor R, Booth M. Adenocarcinoma of the gastric pouch 26 years after loop gastric bypass. Obes Surg. 2006;16(7):935–8.
Nguyen NT, Tran CL, Gelfand DV, et al. Laparoscopic and thoracoscopic Ivor Lewis esophagectomy after Roux-en-Y gastric bypass. Ann Thorac Surg. 2006;82(5):1910–3.
Rogers AM, Capen J, Galka E, et al. Tubulovillous adenoma with atypia found at gastrojejunal anastomosis 8 years after gastric bypass for morbid obesity. Surg Obes Relat Dis. 2007;3(5):559–60.
Sun C, Jackson CS, Reeves M, et al. Metastatic adenocarcinoma of the gastric pouch 5 years after Roux-en-Y gastric bypass. Obes Surg. 2008;18(3):345–8.
Kuruba R, Jawad M, Karl RC, et al. Technique of resection of esophageal adenocarcinoma after Roux-en-Y gastric bypass and literature review of esophagogastric tumors after bariatric procedures. Surg Obes Relat Dis. 2009;5(5):576–81.
Lord RV, Edwards PD, Coleman MJ. Gastric cancer in the bypassed segment after operation for morbid obesity. Aust N Z J Surg. 1997;67(8):580–2.
Khitin L, Roses RE, Birkett DH. Cancer in the gastric remnant after gastric bypass: a case report. Curr Surg. 2003;60(5):521–3.
Escalona A, Guzmán S, Ibáñez L, et al. Gastric cancer after Roux-en-Y gastric bypass. Obes Surg. 2005;15(3):423–7.
Corsini DA, Simoneti CA, Moreira G, et al. Cancer in the excluded stomach 4 years after gastric bypass. Obes Surg. 2006;16(7):932–4.
Harper JL, Beech D, Tichansky DS, et al. Cancer in the bypassed stomach presenting early after gastric bypass. Obes Surg. 2007;17(9):1268–71.
Watkins BJ, Blackmun S, Kuehner ME. Gastric adenocarcinoma after Roux-en-Y gastric bypass: access and evaluation of excluded stomach. Surg Obes Relat Dis. 2007;3(6):644–7.
van de Vrande S, Himpens J, Leman G. Adenocarcinoma of the gastric pouch after Roux-en-Y gastric bypass: a new technique for en bloc resection and reconstruction. Surg Obes Relat Dis. 2017;13(10):1793–5.
Vladimirov M, Hesse U, Stein HJ. Gastric carcinoma after sleeve gastrectomy for obesity. Surg Obes Relat Dis. 2017;13(8):1459–61.
Burton PR, Ooi GJ, Laurie C, et al. Diagnosis and management of oesophageal cancer in bariatric surgical patients. J Gastrointes Surg. 2016;20(10):1683–91.
Tinoco A, Gottardi LF, Boechat ED. Gastric cancer in the excluded stomach 10 years after gastric bypass. Case Rep Surg. 2015;2015:468293.
Maret-Ouda J, Tao W, Mattsson F, et al. Esophageal adenocarcinoma after obesity surgery in a population-based cohort study. Surg Obes Relat Dis. 2017;13(1):28–34.
Masrur M, Elli E, Gonzalez-Ciccarelli LF, et al. De novo gastric adenocarcinoma 1 year after sleeve gastrectomy in a transplant patient. Int J Surg Case Rep. 2016;20:10–3.
Erim T, Colak Y, Szomstein S. Gastric carcinoid tumor after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2015;11(6):e51–2.
Angrisani L, Santonicola A, Iovino P. Gastric cancer: a de novo diagnosis after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2014;10(1):186–7.
Orlando G, Pilone V, Vitiello A, et al. Gastric cancer following bariatric surgery: a review. Surg Laparosc Endosc Percutan Tech. 2014;24(5):400–5.
Scozzari G, Balmativola D, Trapani R, et al. Gastric cancer after restrictive bariatric surgery: a clinical pitfall. Int J Surg Pathol. 2014;22(5):442–6.
Abellán I, Ruíz de Angulo D, Parrilla P. Incidental gastric gastrointestinal stromal tumor (GIST) in the excluded stomach after Roux- en-Y gastric bypass: a case report and review of the literature. Surg Obes Relat Dis. 2014;10(1):e13-4.
Rossidis G, Browning R, Hochwald SN, et al. Minimally invasive esophagectomy is safe in patients with previous gastric bypass. Surg Obes Relat Dis. 2014;10(1):95–100.
Wu CC, Lee WJ, Ser KH, et al. Gastric cancer after mini-gastric bypass surgery: a case report and literature review. Asian J Endosc Surg. 2013;6(4):303–6.
Menéndez P, Villarejo P, Padilla D. Krukenberg tumor after gastric bypass for morbid obesity. Bariatric surgery and gastric cancer. Rev Esp Enferm Dig. 2013;105(5):296–8.
Aggarwal S, Bhambri A, Singla V, et al. Adenocarcinoma of oesophagus involving gastro-oesophageal junction following mini-gastric bypass/one anastomosis gastric bypass. J Minimal Access Surg. 2019;16(2):175–8.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clin Res Ed). 2009;339:b2700.
Higa K, Himpens J, Welbourn R, et al. Third IFSO Global Registry Report 2017. https://e-dendrite.com/Publishing/Reports/Bariatric/IFSO2017.pdf.
Andalib A, Bouchard P, Demyttenaere S, et al. Esophageal cancer after sleeve gastrectomy: a population-based comparative cohort study. Surg Obes Relat Dis. 2021;17(5):879–87.
Parmar CD, Mahawar KK. One anastomosis (mini) gastric bypass is now an established bariatric procedure: a systematic review of 12,807 patients. Obes Surg. 2018;28(9):2956–67.
Parmar CD, Gan J, Stier C, et al. One anastomosis/mini gastric bypass (OAGB-MGB) as revisional bariatric surgery after failed primary adjustable gastric band (LAGB) and sleeve gastrectomy (SG): a systematic review of 1075 patients. Int J Surg. 2020;81:32–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Approval
This type of study does not need ethical approval.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key Points
• This review aims to look at incidence of oesophagogastric (OG) cancer after bariatric surgery (BS).
• This most up-to-date sco** review found 324 cases of OG cancer after BS.
• OG cancer does not seem to be a concern after BS based on this review.
• Future research should focus to optimise screening for oesophageal and gastric cancer after bariatric surgery and its timing.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Parmar, C., Pouwels, S. Oesophageal and Gastric Cancer After Bariatric Surgery: an Up-to-Date Systematic Sco** Review of Literature of 324 Cases. OBES SURG 32, 3854–3862 (2022). https://doi.org/10.1007/s11695-022-06304-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-022-06304-5